A longevity offer is easier to judge when you ask what decision it changes today. Some options support everyday function and preventive care. Others sell a product on the basis of a blood marker, a hormone response or an early study. Those are different outcomes.
Start with the goal: staying active, addressing a diagnosed problem, or evaluating a specific purchase. MedlinePlus describes nutrition, activity, mental health and participation in care as parts of healthy aging. A named supplement or treatment needs a separate test of its proposed result, population and route.
Mochi now publicly lists compounded NAD+ products by nasal, topical and injectable routes, plus compounded injectable sermorelin. The catalog establishes that the offers are advertised, not that they improve healthspan or are appropriate for a given person. Its treatment prices and membership are separate on the public page, and eligibility depends on a provider. Treat those details as questions for an exact quote rather than as a ranking.
By Designing Longevity · Sources checked October 15, 2026 · How we compare
A practical first comparison when the goal is long-term function and health.
The question to answer: Which change fits my health and circumstances?
Judge the exact oral ingredient and meaningful outcome, not the NAD label alone.
The question to answer: Was the result in people like me and was it more than a biomarker?
Read the full explanationMochi advertises compounded forms; oral NR evidence does not establish their outcomes.
The question to answer: What trial tested this exact route and goal?
Read the full explanationNo longevity benefit is established by the cited oral trial; sterile preparation matters.
The question to answer: What evidence and safety controls apply to this exact preparation?
Read the full explanationA historical pediatric drug listing cannot validate a current anti-aging injection.
The question to answer: What current approved product and relevant outcome support this offer?
Read the full explanationAsk whether a study measured daily function, disease risk, cognition or lifespan, or only changed a laboratory marker. A marker can be useful for research without proving that a person will live longer or feel better. NIA says compounds proposed as aging interventions, including NAD, have not been proved to extend lifespan or healthspan in humans.
One randomized oral nicotinamide riboside study in older adults reported a difference in a plasma biomarker but no significant between-group improvement on its cognitive measure. That trial informs a narrow oral precursor question. It does not validate topical, nasal or injectable NAD+ offers.
For supplements, inspect the exact ingredient, dose, quality verification, unwanted ingredients and repeat-order terms. NIA notes that supplements may have interactions and that many have limited evidence of benefit. For a program, ask what the membership actually covers, how the service handles a medical concern and when billing renews.
For injectable services, safety and sourcing questions have additional weight. FDA has described adverse events after compounded NAD+ injectables and unsuitable sterile-compounding ingredients. Historical Geref sermorelin approval does not make a current compounded anti-aging offer FDA approved.
The public longevity page identifies available categories and routes. It does not show a patient-specific eligibility decision, final formulation or full continuing cost. Use it to form questions about a particular offer, while keeping the medical evidence for each route separate. A provider listing is not a study of the provider’s finished product.
No. A biomarker change does not itself establish better function, longer healthspan or lifespan.
They are different substances or routes in different research settings. Evidence for one should not be assigned to the other.
The listing confirms an advertised offer. Efficacy, personal suitability, formulation and exact terms need separate evidence.
We start with a reader’s decision, then separate published facts from our judgment. Government and professional sources support health explanations; a brand’s page supports what it lists, charges or promises. We have not tested these products or assessed individual treatment suitability.
We compare the decision, the studied outcome, the route and the commitment. A laboratory marker is not the same as better daily function, and a study of one formulation cannot establish results for another. We do not assign clinical stars to these options.
Prices and stock reflect the dated check, with missing facts shown explicitly. We withhold expired quotations and product-shopping links that lack the required label review. Monthly editions advance after a completed source check. Product source links use the brands’ public URLs. This content is not medically reviewed.
Linked guides keep their own source dates and limitations.